Covered recipient · General Payments record
CARLOS AARON OLIVAS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2022–2024
$1,046.87
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $332.61 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | $125.01 | 1 |
| ABBVIE INC. | $81.94 | 3 |
| Otsuka America Pharmaceutical, Inc. | $48.97 | 2 |
| Teva Pharmaceuticals USA, Inc. | $28.70 | 1 |
| Neurocrine BioSciences, Inc. | $27.46 | 1 |
| Axsome Therapeutics, Inc. | $20.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.78 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107760946 | CMS |
| ABBVIE INC. | $22.17 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107760948 | CMS |
| ABBVIE INC. | $31.99 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107760950 | CMS |
| Axsome Therapeutics, Inc. | $20.53 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148344598 | CMS |
| Neurocrine Biosciences, Inc. | $27.46 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150946515 | CMS |
| Otsuka America Pharmaceutical, Inc. | $27.49 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119153901 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.48 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119153903 | CMS |
| Phathom Pharmaceuticals, Inc. | $125.01 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151193839 | CMS |
| Teva Pharmaceuticals USA, Inc. | $28.70 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151734405 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.